Remdesivir Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

RecruitingTreatment3 IdentifierTitleDrugs Therapeutics for Inpatients With COVID-19 of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal Modulators for Treating COVID-19 COVID-19 Treatment Trial 4 (ACTT-4) to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting